TW200633721A - A pharmaceutical composition for treating constipation - Google Patents

A pharmaceutical composition for treating constipation

Info

Publication number
TW200633721A
TW200633721A TW094144037A TW94144037A TW200633721A TW 200633721 A TW200633721 A TW 200633721A TW 094144037 A TW094144037 A TW 094144037A TW 94144037 A TW94144037 A TW 94144037A TW 200633721 A TW200633721 A TW 200633721A
Authority
TW
Taiwan
Prior art keywords
hydrogen atom
alkyl group
group etc
lower alkyl
compound
Prior art date
Application number
TW094144037A
Other languages
English (en)
Inventor
Tsutomu Suzuki
Takuko Sawada
Yasunobu Ishihara
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of TW200633721A publication Critical patent/TW200633721A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TW094144037A 2004-12-14 2005-12-13 A pharmaceutical composition for treating constipation TW200633721A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004360966 2004-12-14
JP2005028927 2005-02-04
JP2005111912 2005-04-08
JP2005296045 2005-10-11

Publications (1)

Publication Number Publication Date
TW200633721A true TW200633721A (en) 2006-10-01

Family

ID=36587835

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094144037A TW200633721A (en) 2004-12-14 2005-12-13 A pharmaceutical composition for treating constipation

Country Status (6)

Country Link
US (1) US20090069363A1 (zh)
EP (1) EP1844792A4 (zh)
JP (1) JPWO2006064780A1 (zh)
CA (1) CA2594987A1 (zh)
TW (1) TW200633721A (zh)
WO (1) WO2006064780A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1946759A4 (en) * 2005-10-11 2009-12-23 Toray Industries THERAPEUTIC AGENT AGAINST NAUSEUM AND / OR VOMITING
JPWO2008001859A1 (ja) * 2006-06-30 2009-11-26 学校法人北里研究所 オピオイドδ受容体アゴニスト
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN111905111B (zh) * 2020-09-16 2023-03-31 地奥集团成都药业股份有限公司 一种评价复方谷氨酰胺组方对腹泻型肠易激综合征疗效的方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247206A (en) * 1962-10-05 1966-04-19 Ciba Geigy Corp Diaza-cycloalkane synthesis
US3253989A (en) * 1963-02-11 1966-05-31 American Cyanamid Co Process for producing anorexia
US3751417A (en) * 1971-08-12 1973-08-07 American Cyanamid Co 1-acyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indolines
US4082844A (en) * 1976-02-09 1978-04-04 Merck & Co., Inc. 6-chloro-2-(1-piperazinyl)pyrazine
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US4426383A (en) * 1980-09-04 1984-01-17 Eisai Co., Ltd. Theophylline and theobromine derivatives
DE3364234D1 (en) * 1982-03-02 1986-07-31 Eisai Co Ltd Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient
US4457931A (en) * 1982-09-27 1984-07-03 Selvi & C. S.P.A. Piperazine derivatives with anticholinergic and/or antihistaminic activity
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
IN164921B (zh) * 1986-07-22 1989-07-08 Hoechst India
ES2061953T3 (es) * 1988-11-24 1994-12-16 Akzo Nv Un procedimiento para preparar una composicion farmaceutica.
EP0636371B1 (en) * 1992-12-22 1998-05-20 Toray Industries, Inc. Antitussive
JPH11500123A (ja) * 1995-02-15 1999-01-06 ファルマシア・アンド・アップジョン・カンパニー ＣＮＳおよび心臓病の治療のためのイミダゾ［１，２−ａ］ピリジン類
AU712012B2 (en) * 1995-09-26 1999-10-28 Toray Industries, Inc. Indole derivatives and medical application thereof
JP4076234B2 (ja) * 1996-06-28 2008-04-16 明治製菓株式会社 テトラヒドロベンズインドール化合物
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
KR100508626B1 (ko) * 1997-06-27 2005-08-17 니폰 가야꾸 가부시끼가이샤 빈뇨·요실금 치료·예방제 및 트로폰 유도체
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
US6465467B1 (en) * 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
EP1204654B1 (en) * 1999-07-29 2003-07-23 Eli Lilly And Company Benzofurylpiperazines: 5-ht2c serotonin receptor agonists
ATE275402T1 (de) * 1999-11-01 2004-09-15 John Rhodes Arzneimittel zur behandlung von darmverstopfung und reizkolon
PT1244447E (pt) * 1999-11-29 2007-02-28 Adolor Corp Métodos e composições inovadoras envolvendo opióides e antagonístas opióides
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
US20030073701A1 (en) * 2001-03-31 2003-04-17 Thompson Lorin A. Succinoylamino heterocycles as inhibitors of a beta protein production
US20040024004A1 (en) * 2001-05-04 2004-02-05 Sherman Barry M. Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists
US6683093B2 (en) * 2000-05-12 2004-01-27 Pharmacia Corporation Aromatic sulfone hydroxamic acids and their use as protease inhibitors
GB0025056D0 (en) * 2000-10-12 2000-11-29 Smithkline Beecham Spa Novel compounds
AU2403802A (en) * 2000-11-15 2002-05-27 Banyu Pharma Co Ltd Benzimidazole derivatives
GB0030710D0 (en) * 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
CA2432985A1 (en) * 2001-01-23 2002-08-01 Vincent Mancuso Piperazine- and piperidine-derivatives as melanocortin receptor agonists
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
DE10134721A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Tetrahydrochinoxaline
CA2430328A1 (en) * 2001-09-28 2003-04-10 Kyowa Hakko Kogyo Co., Ltd. Receptor antagonist
DK2939696T3 (en) * 2001-10-18 2016-05-23 Nektar Therapeutics Polymer Conjugates of Opioid Antagonists
JP2005289816A (ja) * 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
US7129354B2 (en) * 2002-06-19 2006-10-31 Biovitrum Ab Process for the preparation of stable acid addition salt of 2,3-disubstituted pyrazine compounds
US20060052409A1 (en) * 2002-07-11 2006-03-09 Koji Kawai Therapeutic or preventive agent for nausea/vomiting
JP2007523861A (ja) * 2003-06-20 2007-08-23 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｎ−フェニル−ピペラジン誘導体および５ｈｔ２ｃレセプター関連疾患の予防方法または処置方法
PE20060185A1 (es) * 2004-04-21 2006-03-20 Schering Corp ANTAGONISTA DEL RECEPTOR A2A DE LA ADENOSINA CON ESTRUCTURA DE PIRAZOLO--[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA
BRPI0609268A2 (pt) * 2005-03-31 2010-03-09 Pfizer Prod Inc derivados de ciclopentapiridina e tetraidroquinolina

Also Published As

Publication number Publication date
JPWO2006064780A1 (ja) 2008-06-12
WO2006064780A1 (ja) 2006-06-22
CA2594987A1 (en) 2006-06-22
EP1844792A4 (en) 2008-05-21
EP1844792A1 (en) 2007-10-17
US20090069363A1 (en) 2009-03-12

Similar Documents

Publication Publication Date Title
TW200633721A (en) A pharmaceutical composition for treating constipation
RS20090249A (en) Spiroketone acetyl-coa carboxylase inhibotors
TW200726470A (en) 6,7-unsaturated-7-carbamoylmorphinan derivatives
TW200730501A (en) Heterocyclic derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase I
BRPI0413233A (pt) novos compostos
SG162790A1 (en) Aspartyl protease inhibitors
TW200726765A (en) Triazolopyridine cannabinoid receptor 1 antagonists
TW200716576A (en) Heterocyclic derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
MX2010003950A (es) Derivado de amina que tiene actividad antagonista del receptor y5 de neuropeptido y (npy) y uso del mismo.
ATE289602T1 (de) Quinolin-2-on-derivate verwendbar als antikrebsmittel
MX2007007428A (es) Compuestos heterociclicos, antagonistas de ccr2b.
UA86957C2 (ru) Производные азепиноиндола в качестве фармацевтического средства
TW200734322A (en) Indole derivatives exhibiting PGD2 receptor antagonism
TW200716644A (en) Aspartyl protease inhibitors
AP1541A (en) New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
TW200630361A (en) Integrin antagonists useful as anticancer agents
TW200800938A (en) Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism
TW200716645A (en) Macrocyclic heterocyclic aspartyl protease inhibitors
GEP20125456B (en) Azetidines as mek inhibitors for the treatment of proliferative diseases
AP1816A (en) 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists.
NZ596470A (en) Hydrochloride salt of ((1s,2s,4r)-4-{ 4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl} -2-hydroxycyclopentyl)methyl sulfamate
JO2652B1 (en) Compounds 5,4,2,1 Tetra Hydro-H3-benzazepine Method of preparation and pharmaceutical compounds containing
PL361361A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
NO20062255L (no) 4-anilino-3-kinolinkarbonitriler for behandling av kronisk myelogenos leukemi (CML)
TW200612965A (en) Methods for preparing p2x7 inhibitors